Skip to content
Live newsroom 138 readers online
Wednesday, August 26, 2026 Live Sync: Just now
Demystifying Finance, Technology, and Global Markets for the Next Generation.
BreakingRupert Grint returning to Harry Potter as Ron Weasley in Broadway show
Technology & Future Tech

Lycopodium Ltd (LYOPF) (FY 2026) Earnings Call Highlights: Record Revenue and Strong FY27 …

This article first appeared on GuruFocus. For the complete transcript of the earnings call, please refer to the full earnings call transcript. Lycopodium Ltd (LYOPF) delivered record revenue of $377.5 million, up 11% year-over-year, with NPAT of $40.2 million at the top end of guidance. The company has a record level of committed work, with […]

By deepak · August 19, 2026 · 2 min read

This article first appeared on GuruFocus.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Lycopodium Ltd (LYOPF) delivered record revenue of $377.5 million, up 11% year-over-year, with NPAT of $40.2 million at the top end of guidance.

The company has a record level of committed work, with just under 70% of FY27 revenue guidance already secured, providing strong earnings visibility.

Lycopodium Ltd (LYOPF) is expanding its geographic diversification, highlighted by its first material full EPCM award in South America (Monera San Cristabel project in Bolivia).

The study pipeline has more than doubled since December, with over 90 studies currently underway, indicating a robust future project pipeline.

The company maintains a strong balance sheet with $106.2 million in cash and minimal debt, supporting its capital-light business model and dividend payments.

Management provided early FY27 guidance for revenue of $540-$580 million and NPAT of $54-$58 million, reflecting high confidence in continued growth.

Lycopodium Ltd (LYOPF)'s revenue is heavily concentrated in Africa (58%), exposing the company to potential sovereign and execution risks in those jurisdictions.

The company's FY27 revenue guidance implies a significant 50% year-on-year growth, with over 30% of the target still dependent on projects that have not yet formally committed.

Rapid expansion in the Americas requires additional investment in office space and headcount in Toronto, Vancouver, and Lima, which could pressure short-term margins.

The company faces execution risks on large, complex projects like the Blackwater Phase 2 expansion, which management acknowledged will come with challenges.

While the study pipeline is strong, conversion to project awards is not guaranteed, with management noting that only about 70% of advanced studies typically convert to execution work.

The business is scaling up its workforce (from 1,400 to 1,500 employees) to meet demand, which could lead to cost overruns or inefficiencies if growth is not managed carefully.

Warning! GuruFocus has detected 7 Warning Sign with LYOPF.

Source: Read the original article on ca.finance.yahoo.com